Latest Strategy News

Page 78 of 900
Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.
Ada Torres
Ada Torres
27 Nov 2025
DGR Global Limited highlights a significant re-rating of its SolGold investment, driven by SolGold’s strategic staged development and updated resource estimates at the Cascabel copper-gold project in Ecuador.
Maxwell Dee
Maxwell Dee
27 Nov 2025
Thunderbird Resources has completed its acquisition of LM2 Metals, gaining full ownership of the Springfield Gold Deposit in central NSW and issuing over 28 million shares as part of the deal.
Maxwell Dee
Maxwell Dee
27 Nov 2025
Uscom Limited reported a 25% revenue decline in FY25 amid global geopolitical challenges but reinforced its commitment to growth through strategic partnerships and innovative medical technologies.
Ada Torres
Ada Torres
27 Nov 2025
Hexima Limited reveals plans to return capital to shareholders and restructure its board following the closure of its main clinical program and prolonged ASX trading suspension.
Ada Torres
Ada Torres
27 Nov 2025
SDI Limited reported stable FY25 revenue with improved margins and advancing Montrose project, while regional sales showed mixed results.
Ada Torres
Ada Torres
27 Nov 2025
SDI Limited reported a steady FY2025 with a slight profit increase, driven by growth in aesthetic and whitening products and the launch of its new amalgam replacement, Stela. The company also announced plans for a new factory to boost production capacity.
Ada Torres
Ada Torres
27 Nov 2025
Reward Minerals has secured 100% ownership of the Copper Lance Project in Newfoundland, initiating field sampling to validate historic high-grade copper, silver, and gold mineralisation. The project reveals multiple undrilled anomalies and new exploration targets in a prolific VMS district.
Maxwell Dee
Maxwell Dee
27 Nov 2025
Swoop Holdings Limited showcased robust subscriber growth and strategic divestments at its November 2025 AGM, targeting significant margin improvements and operational efficiencies.
Sophie Babbage
Sophie Babbage
27 Nov 2025
Recce Pharmaceuticals has secured a key patent in Hong Kong for its synthetic anti-infectives, reinforcing its intellectual property footprint in Asia and supporting its clinical and commercial ambitions in the region.
Ada Torres
Ada Torres
27 Nov 2025
Chris Wright resigns as CEO of AUCyber after overseeing key restructuring, with no immediate replacement planned due to integration with 5G Networks.
Sophie Babbage
Sophie Babbage
27 Nov 2025
Ballymore Resources’ maiden reverse circulation drilling at the historic Torpy’s silver-lead-zinc mine reveals significant high-grade mineralisation, prompting a strategic pause for downhole EM surveys to refine exploration targets.
Maxwell Dee
Maxwell Dee
27 Nov 2025